CME Group Inc. (NASDAQ:CME – Get Free Report) was the recipient of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 4,420,000 shares, a growth of 18.2% from the March 15th total of 3,740,000 shares. Based on an average daily volume of 1,750,000 shares, the short-interest ratio is presently 2.5 days. Currently, 1.2% of the company’s stock are sold short.
Wall Street Analysts Forecast Growth
Several research analysts recently commented on the company. Argus increased their price target on CME Group from $225.00 to $245.00 and gave the company a “buy” rating in a research report on Wednesday, March 6th. Morgan Stanley raised their price objective on CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a research report on Tuesday, April 9th. Rosenblatt Securities reaffirmed a “sell” rating and issued a $180.00 price objective on shares of CME Group in a research report on Thursday, January 4th. Barclays raised their price objective on CME Group from $225.00 to $226.00 and gave the company an “equal weight” rating in a research report on Monday, April 8th. Finally, Keefe, Bruyette & Woods reaffirmed a “market perform” rating and issued a $229.00 price objective on shares of CME Group in a research report on Wednesday, April 3rd. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $215.70.
Check Out Our Latest Research Report on CME
Hedge Funds Weigh In On CME Group
CME Group Trading Down 1.6 %
Shares of CME opened at $206.23 on Tuesday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group has a 52-week low of $175.73 and a 52-week high of $223.80. The firm has a market cap of $74.24 billion, a price-to-earnings ratio of 23.25, a PEG ratio of 5.95 and a beta of 0.49. The business’s fifty day moving average is $214.01 and its 200-day moving average is $211.60.
CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings results on Wednesday, February 14th. The financial services provider reported $2.37 EPS for the quarter, topping analysts’ consensus estimates of $2.27 by $0.10. CME Group had a return on equity of 12.32% and a net margin of 57.83%. The company had revenue of $1.44 billion during the quarter, compared to analysts’ expectations of $1.43 billion. During the same quarter in the previous year, the firm earned $1.92 EPS. CME Group’s revenue was up 19.2% on a year-over-year basis. Equities analysts anticipate that CME Group will post 9.56 EPS for the current fiscal year.
CME Group Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 26th. Shareholders of record on Friday, March 8th were issued a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a yield of 2.23%. The ex-dividend date of this dividend was Thursday, March 7th. This is a boost from CME Group’s previous quarterly dividend of $1.10. CME Group’s dividend payout ratio is presently 51.86%.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
- Five stocks we like better than CME Group
- Canadian Penny Stocks: Can They Make You Rich?
- The Charles Schwab Company Can Hit New Highs
- Bank Stocks – Best Bank Stocks to Invest In
- Costco vs. Walmart: Revenue Comparison of Two Retail Giants
- What Is WallStreetBets and What Stocks Are They Targeting?
- 3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.